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Hemodynamic and Neural Mechanisms of 
Action of Thyrotropin-Releasing Hormone 
in the Rat 
A.-L. Sin~n, C.R. Lake, and G. Feuerstein 
Tbe mechanisms mediating the etl'ects ofthyrotropin-releasing hormone (TRH) on the cardiovascular 
system were studied in the conscious rat. Intracerebroventricolar (i.c. v.) injection of TRH (8 pmol-80 
nmollkg) induced dose-dependent lncreases in mean arterial pressure, heart rate, and cardiac index. 
Rindquarter blood Oow increased due to vasodilation, while an lncrease in renal and mesenteric 
vascular resistance caused a decrease in blood Oow in the respective organs. The plasma Ievels of 
norepinephrine a~d epinephrine were increased by TRH, while there was no change in plasma renin 
activity or vasopressin. Tbe cardiovascular actions of i.c. v. TRH were not in.fluenced by blockade of 
the renin-angiotensin system or vasopressin receptors. Tbe ganglion blocker chlorisondamine and the 
a 1- aod al-adrenoreceptor antagooist phentolamlne (2 mg/kg i.v.) abolished the increase in blood 
pressure and mesenteric vasoconstriction after i.c. v. TRH. Propranolol (2 mg/kg i. v.) blocked the 
TRH-ioduced increase in cardiac index, heart rate, and hindquarter blood flow. The hindquarter 
vasodllatlon lnduced by TRH was also blocked by the selective ß1-adrenocept9r antagonist ICI 188,551 (1 or 2 mg/kg i.v.), while tbe ,8,-adrenoceptor blocker practolol (10 mg/kg i.v.) had no eft'ect on the 
hindquarter vasodiJation produced by TRH but totally blocked the increase in cardiac Index. In 
adrenal demedullated rats, the systemic hemodynamic eft'ects ofi.c. v. TRH were dimlnished along with 
the decrease in renal blood flow and lncrease in renal vascular resistance; however, the iocrease in 
hfndquarter blood flow was attenuated only in adrenal demedullated rats pretreated with the 
sympathetlc blocker bretylium. The renal vasoconstriction induced by i.c. v. TRH was not abolished 
by renal denervation. In sinoaortic debufl'ered rats, the pressor, tachycardic, and mesenteric 
vasoconstrictor responses to centrally administered TRH were significantly potentiated. Taken 
together, these data soggest that the putative rieurotransmitter TRH may play a role in central 
regulation of cardiac functions and organ blood flow distribution through both tbe sympathetic nerves 
and the adrenal medulla. A pivotal roJe for ß1-adrenoceptors in mediation ofhindquarter vasodilation 
ls also demonstrated. (Circulatlon Research 1988;62:139-154) 
T. hyrotropin·releasing hormone (TRH, L·pyro-glutamyl·L-histidyl-L·prolinamide) was the first hypothalamic releasing factor to be iso-
lated, chemically characterized, and synthesized (for 
review, see Prasad1). In addition to its endocrine actions 
(thyrotropin, prolactin, and growth hormone release), 
TRH elicits multiple autonomic effects (e.g., arousal, 
analeptic effect, increased locomotor activity, and 
changes in body temperature, respiration, blood pres-
sure, and heart rate) that are unrelated to its action on 
the hypothalamic pituitary axis (for review, see 
Horita et al,2 Griffiths, 3 and Prasad'). Thus, cardio-
respiratory responses to intracerebroventricularly 
(i.c. v.) administered TRH have been reported in 
hypophysectomized4" and thyroidectomized rats.6 Fur· 
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thermore, TRH and TRH receptors are widely distrib-
uted throughout the central nervous system (CNS)'- 11 
with more than 70% of the total CNS TRH found in 
extrahypothalamic areas. 7 The local ization of TRH in 
synaptic nerve endings, its release by synaptic termi-
nals, its binding to high-affinity receptors, and the 
presence ofbrain peptidases capable of inactivating the 
tripeptide'·7 strongly suggest that TRH may serve as a 
neurotransmitter or neuromodulator in the CNS. 
Increases in mean arterial pressure (MAP) and heart 
rate by TRH have been demonstrated in several studies 
and by various routes of TRH administration.'2- 17 The 
card iovascular effects of TRH are I ikely to be of central 
origin, since thedoses needed toelicit rises ofMAP and 
heart rate after systemic injections'2·'6 are 1,000 times 
higher than the doses used i.c. v.'4·'8•111 or for injections 
into discrete brain nuclei. 15•17 Also, transections in the 
cervical spinal cord of anesthetized rabbits abolished 
the pressor response to i.c. v. administered TRH'1; 
furthermore, the pressor effects of TRH are also totally 
abolished in the pithed rat in which the entire CNS and 
cardiac reflexes are elirninated. 15•16 In addition, micro-
injections of picomolar doses of TRH into preoptic or 
hypothalamic nuclei of anesthetized rats produced 
increases in blood pressure and heart rate without 
changes in body temperature or respiration. 17 A role for 
TRH in central regulation ofthe cardiovascular system 
is also suggested from its presence in cells and fibers 
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along with high-affinity receptors in brain nuclei 
important for cardiovascular homeostasis (e.g., peri-
ventricular and arcuate nuclei of hypothalamus, amyg-
dala, nucleus of the solitary tract, and dorsal motor 
nucleus of the vagus). 7·8•10•11 
At the present time, the neural and humoral mech-
anisms involved in the cardiovascular actions of TRH 
are not clear. Stimulation of the sympathoadreno-
medullary system by TRH seems evident because, 
concomitantly with its pressor effect, TRH produces 
rises of plasma catecholamines in both animals "·20 and 
man. 21 RecentJy, increased efferent sympathetic activ-
ity in the renal, cervical, and splanchnic nerves of the 
anesthetized rat was reported after TRH i.c. v.' The 
cardiovascular effects of TRH have been shown to be 
attenuated by adrenal demedullation and by sympa-
thetic blockers in some studies,'· 12·''· 17 while no in-
volvement for sympathetic or parasympathetic nervaus 
system was found in others.4 •18 Also, although the 
pressor etfect of TRH has been repeatedly reported in 
many experimental animals (see above) andin man, 21 - 23 
little is known about the discrete hemodynamic mech-
anisms involved in the cardiovascular actions of TRH. 
In view of the present controversy over the role of 
the sympathetic nervous system in mediation of TRH 
effects and the apparent Iack of knowledge on the 
discrete hemodynamic actions of T~H, we decided to 
examine the effect of TRH on cardiac output and 
regional blood ftow of conscious rats after select-
ive sympathetic denervation or adrenal demedullation 
and by pharmacologic tools such as adrenolytic and 
adrenergic blocking agents. 
Materials and Methods 
Male Sprague-Dawley rats (260-340 g) from Ta-
conic Farms (Germantown, N.Y.) were used in all 
experiments. In a separate series of experiments, 
bilaterally adrenal demedullated (Adm-x) rats (from 
the same source) were also used. After the surgical 
procedures, rats were housed individually in plastic 
cages (21 X 27 X J 6 cm, W XL X H) with food and 
water ad libitum. 
Measurement of Cardiac Output 
The etfect of TRH on cardiac output and total 
peripheral resistance (TPR) was studied as follows: 
Rats were anesthetized with an intramuscular injection 
of 0.13 mV 100 g of I 00 mg/ml ketamine and I mg/ml 
acepromazine, and PE-50 tubing was inserted into the 
femoral arteries. The catheters were tunneled beneath 
the back skin and exteriorized at the back of the neck. 
Then, an incision was made at the midline of the neck 
from the cricoid to the clavicle, and PE-50 tubing was 
inserted into the right atrium through the external 
jugular vein. Then, the left common carotid artery was 
exposed and ligated, and a thermistor (model MX2-
780-33 THMP f# 1.5, Teflon reusabJe, CoJumbus 
Instruments, Columbus, Ohio) was advanced through 
the carotid into the aseend ing aorta (placement above 
the aortic valve was confirmed in each animal at the end 
ofthe experiment and by the shape ofthe dilution curve 
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before the probe was finally sutured to the neck 
muscles). The jugular vein catheter and the thermistor 
were tunneled under the skin to the back of the neck. 
Alliines were secured by a soft spring wire (attached 
by an adhesive collar) from the back of the neck and 
outside of the cage. The animals were allowed to 
recover from surgery for 24-48 hours. On the day of 
the experiment, the arterial line was connected to a 
blood pressure transducer (Narco RP 1500i), and 
continuous recordings of blood pressure (systolic, 
diastolic, and mean) and heart rate were recorded by 
the Narcotrace 80 computerized dynograph. The car-
diac outputwas measured by thermodilution technique 
by. the thermistor attached to the computerized Car-
diomax II (model CM x 2-780-k with the microprobe 
option R, Columbus Instruments). The dead space of 
the venous line was first ftushed with 0.05 ml of 0.9% 
(wtlvol) NaCl (saline) at room temperature, 22° C; after 
a brief stabilization period (10 seconds to ensure 
normal core temperature), an additional injection of 
0. 2 ml normal saline (22° C) was rapidly injected using 
a 1-ml syringe. Cardiac output was recorded in the 
following manner: A control period of 15 minutes 
included 2 or 3 cardiac output measurements to test for 
consistency and placement of the probe and to get 
control values for MAP and heart rate. The timer on the 
automatic data collection systemwas started, and data 
points were taken at to. t2, t.5, t10 , t.,, t30 , and t., minutes. 
Increasing doses of TRH or sal ine were injected i.c. v. 
at 45-minute intervals. TPR was calculated by dividing 
MAP by the cardiac output; values of cardiac output 
and TPR were further indexed per unit of weight (kg). 
In a separate set of rats (n = 6), central venous 
pressurewas monitared via the jugularcatheter with the 
tip advanced into the upper thoracic vena cava. The 
thermodilution probe was also inserted into the aorta 
to allow concomitant measurements of cardiac output. 
A single bolus dose of TRH (8 nmollkg) was injected 
i.c. v. 24-48 hours after surgery, and the changes in 
central venous pressure and MAP were followed for 45 
minutes. Cardiac output measurements were taken 5, 
15, and 30 minutes after TRH administration. Control 
Ievels for central venous pressure were taken while the 
pressure gauge was placed 3 cm above the animal's 
cage ftoor. 
In the past, we have used the thermodilution 
method for cardiac output measurements in both 
anesthetized and conscious rats. 24 Although the car-
diac output values obtained by the thermodilution 
technique are somewhat higher than those deter-
mined by electromagnetic ftowmetry2.5.26 or by radio-
aclive microsphere method, 27•28 the values reported by 
us are within the range of cardiac output in the 
conscious rat obtained by other investigators using the 
thermodilution technique. 2.5.29-Jr 
Regional Blood Flow Measurements With Directional 
Pulsed Doppler Technique 
Another set of rats was used to study the effect of 
TRH on regional blood ftow and vascular resist-
ance. The animals were anesthetized with ketamine-
Sirbr et al Tbyrotropln-Releasing Hormone 
acepromazine (see above). Miniaturized Doppler ftow 
probes (Valpey-Fisher, Hopkinton, Mass.) were su-
tured around the abdominal aorta, the superior mesen-
teric artery, and the left renal artery according to the 
method described earlier by Haywood et al. 32 Briefty, 
a midline laparotomy was made, and 4-mm lengths of 
the lower abdominal aorta below the left renal artery, 
the superior mesenteric artery, and the left renal artery 
were carefully isolated with the aid of a dissecting 
microscope. Miniaturized Doppler ftow probes were 
then sutured around each vessel. The wire Ieads were 
tunneled beneath the skin and exteriorized at the nape 
of the neck where they were soldered to a connector 
plug that was fixed to the animal's skull with small 
screws and dental acrylic cement. Polyethylene cath-
eters (PE-50) were implanted in the left femoral artery 
and vein for measurements of blood pressure and heart 
rate and for intravenous drug injections. The catheters 
were led beneath the back skin to exit at the nape of the 
neck and were then secured by a spring wire as 
described above. The animals were allowed to recover 
for 3-5 days after surgery. 
On the day of the experiment, the rat was connected 
to.the flow probe wire connector, and the connector line 
was suspended from the top of the animal' s home cage 
to allow freedom of movement during the experiment. 
Regional blood flow was measured with a pulsed 
Doppler ftowmeter (model #545c-3, University of 
Iowa Bioengineering Facility, Iowa City, Iowa). The 
arterialline was attached to a pressure transducer (as 
above), and blood pressure, heart rate, and regional 
blood ftows were continuously recorded on the Narco 
dynograph. Vascular resistance was calculated by 
dividing MAP by bl~ velocity (Doppler shift in 
kilohertz). Changes in blood ftow and vascular resis-
tance are expressed as a percent of control values. 
lntracerebroventricular lnjections 
Rats were anesthetized with ketamine-acepromazine 
(see above) and placed on a stereotaxic device (David 
Kopf Instruments, Calif.). A stainless steel guide 
cannula was inserted through the skull and fixed with 
glue (Eastman 910 adhesive). Coordinates for the 
injections into the right lateral brain ventricle (i.c. v.) 
were measured from the bregma: AP = - 0. 8 mm and 
L= 1.2 mm. On the day of the experiment, injections 
of saline or TRH were made using a premeasured 30-g 
(7 .5-mm) cannula inserted into the ventricular space 
through the guide cannula. The injection cannula was 
then connected via polyethylene tubing to a Hamilton 
microliter syringe, and a volume of 10 p.l ofthe control 
or drug solution was injected over a period of 30 
seconds. The proper position of the i.c. v. cannula was 
determined at the end of each experiment by an 
injection of dye (methylene blue) into the cerebral 
ventricles. 
Experimental Protocols 
Dose-response studies. The effect of TRH on 
systemic and regional hemodynamics was studied 
by injections of increasing doses of TRH (8 pmol-
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80 nmoUkg) or saline i.c.v. at 30-45-minute intervals. 
ln.fluence of adrenergic blockers. The effect ofb1ock-
ade of autonomic ganglia or a- and ß-adrenergic 
receptors on the TRH-elicited hemodynamic changes 
were studied in a separate series of rats. First, the rat 
received i.c. v. injections of saline and TRH (8 nmollkg) 
at 30-minute intervals. Chlorisondamine (5 mglkg), 
phentolamine (2 mglkg), propranolol (2 mglkg), prac-
tolol (10 mglkg), or ICI 118,551 (1-2 mglkg) were 
injected intravenously 15-20 minutes before a single 
i. c. v. dose of TRH (8 nmol/kg); a separate group of rats 
was used for each of these experiments. This dose of 
TRH was chosen because in the preliminary experiments 
it produced a significant and reproducible change in 
cardiovascular variables. The effectiveness of the sym-
pathetic blockadewas tested each time against bolus i. v. 
doses of norepinephrine or epinephrine (0.3 and I 
JLg/kg, respectively). 
Effect of captopril and Sarl/leB-angiotensin ll. The 
potential role of the renin-angiotensin system in the 
cardiovascular actions of TRH was studied in 6 
additional rats. Captopril ( 1.5 mg!kg) and Sar1 ,lle8-
angiotensin II (Sar1 ,Ile8-Angm (0.1 mg!kg) were in-
jected intravenously 10 and 15 minutes, respectively, 
before a single i.c.v. dose of TRH (8 nmoVkg). 
Effect of a vasopressin antagonist. The influence 
of a vasopressin antagonist, PMP1-0-methyl-1Yr-
[Arg8]vasopressin, on the TRH actions was studied in 
5 additional rats. The vasopressin antagonist (150 
JLg/kg) was injected intravenously 5 minutes before a 
single i.c. v. dose ofTRH (8 nmollkg). This dose ofthe 
antagonist effectively blocked the pressor and vaso-
constrictor effects of [Arg!]vasopressin (0.03-0.1 
p.glkg i. v.). 
Effect of TRH in adrenal demedullated rats. The 
effect of TRH on hemodynamic and biochemical 
variables was also studied in bilaterally Adm-x rats. 
The rats were used 10 days after the adrenal de-
medullation. Some of these animals were treated with 
bretylium. Bretylium (30 mg!kg) was injected slowly 
(over 45 minutes) in 3 separate doses (10 mglkg each) 
120 minutes before i.c.v. administration of saline (10 
JLI} or TRH (8 nmoVkg). Complete demedullation was 
confirmed in all the demedullated rats by direct assay 
of plasma epinephrine, and only rats with undetectable 
Ievels of epinephrine were used. 
Sinoaortic denervation. In a separate group of rats, 
sinoaortic baroreceptors deafferentation (SAD) was 
performed according to the method described by 
Krieger. 33 One week before the experiments, the rats 
were anesthetized with ketamine-acepromazine (see 
above) and given an injection of atropine (0.4 mg/rat 
i.p.). Amidventral neck incision was made, and both 
of the carotid sinuses were exposed. The superior 
laryngeal nerve and cervical sympathetic chains were 
cut. Nervesegments of0.5 cm were removed to prevent 
the possibility of reconnection; all connective tissue 
and nerves were stripped from the internal, external, 
and comrnon carotid arteries and the occipital and 
thyroid arteries along 0.5 cm of their length extending 
from the carotid bifurcation region: In addition, the 
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vessels were painted with I 0% phenol, and special 
attention was devoted to avoid darnage to the vagus 
nerve or other nearby structures. In addition to the SAD 
surgery, head cannulas for i.c. v. injections and Doppler 
flow probes were implanted as described above. 
1\venty-four hours before the experiments, the animals 
were anesthetized with halothane (2% in oxygen), and 
arterial and venous lines were inserted into the femoral 
vessels as described above. The adequacy of the 
baroreceptor deafferentation procedure was assessed 
prior to any interventions by evaluating the maximal 
heart rate changes to phenylephrine ( 1 and 3 ~glkg 
i. v.). For all studies, only SAD animals exhibiting a 
decline in heart rate of less than 15 beats/min were 
selected. Saline (10 ~I) and TRH (8 nmol!kg) were 
injected i.c. v. at 60-minute intervals. 
Renal denervation. Another group of rats underwent 
unilateral renal denervation (ketamine-acepromazine 
anesthesia) 1 week before the experiment. Through a 
midline ventrallaparotomy, left renal denervation was 
performed by stripping the renal artery and vein of 
adventitia, cutting the renal nerve bundles, and coating 
the vessels with a solution of I 0% phenol in absolute 
ethanol. Implantation of head cannulas for i.c. v. 
injections and of Doppler flow probes on both left and 
right renal artefies was also performed. One day before 
the experiment, the rats were anesthetized with halo-
thane (2% in oxygen), and arterial and venous lines 
were implanted into the femoral vessels as described 
previously. To confirm the success of renal denervation, 
the tissue catecholamine content was measured from 
bot}J kidneys. The norepinephrine content of the 
denervated side was significantly reduced to less than 
5% of that of the intact kidney. TRH (8 nmol/kg) and 
saline were injected i.c. v. at 60-minute intervals. 
Before the start of the i.c. v. injections, an intravenous 
dose of norepinephrine ( 1 ~g!kg) was injected to test 
the reactivity of the Doppler lines. 
Remadynamie effects of systemically administered 
TRH. The effect of a single systemic dose ofTRH (5.5 
~molfkg) on the cardiovascular systemwas studied in 
rats equipped with thermodilution probe for cardiac 
index measurement or Doppler ftow probes for discrete 
organ blood ftow measurement. 
Ejfect ofTRH on plasma catecholamines, vasopres-
sin, and renin activity. To evaluate the effect of TRH 
on plasma catecholamines, vasopressin, and renin, 
PE-50 tubings were implanted in the femoral vessels as 
described. Blood samples (0.5 ml) were collected prior 
to and at the peak of TRH effect (3 minutes after TRH) 
and 30 minutes later. Each blood sample withdrawn 
was replenished with fresh blood from donor rats. 
ASSAY OF PLASMA CATECHOLAMINES. In experiments in 
which the influence ofTRH on plasma catecholamines 
and renin Ievels was studied, a single systemic dose of 
TRH (5.5 ~mol/kg) was injected into the arterialline. 
Blood samples for measurement of plasma norepineph-
rine and epinephrine concentrations were obtained 
before and 5 and 30 minutes after TRH injection, as 
previously described. :w Blood specimens were col-
lected in chilled heparinized test tubes, placed on ice, 
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and centrifuged within 10 minutes of collection, and 
the plasma was separated and stored at - 70° C until 
assayed. The sarne experimental protocol was used to 
study the effects of TRH on plasma catecholamines in 
Adm-x rats (see below). · · 
Plasma norepinephrine and epinephrine concentra-
tions were measured by a radioenzymatic teclmique in 
which a partially purified enzyme, catechol-0-
methyltransferase (COMT), catalyzed the transfer of 
a [3H]S-adenosylmethionine to the metahydroxyl group 
of endogenous norepinephrine and epinephrine, form-
ing ['H]normetanephrine and [lH]metanephrine, re-
spectively. The resultant measurements were accurate 
above the value of 20-30 pg norepinephrine or 
epinephrine/ml plasma (2-3 pg/tube). 
In a separate set of rats (n = 6), increasing doses of 
epinephrine (0.1-1 ~glkg) were injected intravenously, 
and blood pressure and regional blood flows as weil as 
plasma epinephrine Ievels were monitored. Blood 
samples (0.5 ml) were withdrawn before epinephrine 
injection and during the peak of the hemodynamic 
changes. Each blood sample withdrawn was replen-
ished with fresh blood from a donor rat. 
ASSAY OF PLASMA RENIN ACllVJTY. A Single dose of 
TRH (5.5 ~moVkg) was injected intra-arterially, and 
blood samples were collected before and 5 and 30 
minutes after TRH injection. Plasma was collected by 
dripping 300 ~I of blood from arterial line directly 
into ice-cold vials containing 50 ~~ of 10% EDTA. 
The samples were then immediately centrifuged, and 
the plasma frozen on dry ice. The plasma samples 
were sent frozen on dry ice to Dr. K.B. Brosnihan 
(Cleveland Clinic, Cleveland, Ohio) for analysis. The 
plasma renin activity (PRA) was assayed as previously 
described by Sen et aP' The generated angiotensin I 
was measured by radioimmunoassay (RIA for Angio-
tensin I, New England Nuclear, Boston, Mass.). The 
baseline Ievels of PRA in our study are in accord with . 
the PRA in conscious rats reported earl ier by Sen and 
coworkers. 3' 
ASSAY OF ARGININE VASOPRESSIN. Plasma remaining 
after removal of a fraction for catecholamine determi-
nationwas stored at -20° C and sent frozen on dry ice 
to Dr. R.L. Zerbe (Eli Lilly & Co., Lilly Research 
Labs, Indianapolis, Ind.) for subsequent measurement 
of plasma vasopressin by RIA. 36 The assay consistently 
detects 0.2 pg of arginine vasopressin/tube and cross-
reacts less than 1% with oxytocin. The intraassay 
coefficient of variation is 24% at 1 pg, 4% at 5 pg, and 
6% at 20 pg. All plasma samples in this study were 
extracted at the same time and measured in the same 
assay. 
Drugs Used 
The following drugs were used: Thyro-
tropin-releasing hormone (TRH) (Sigma ChemicaJ 
Co., St. Louis, Mo.), bretylium tosylate (kindly 
provided by American Hospital Supply Co.), d,l-
propranolol hydrochloride, phenylephrine, 1-epi-
nephrine, l-norepinephrine, dopamine hydrochloride, 
[Arg']vasopressin, PMP'-0-methyl-Tyr-(Argl]vaso-
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pressin (Peninsula), captopril (Squibb), Sar1, 
Ile8-angiotensin II (Peninsula), phentolamine (Ciba), 
and practolol and ICI 118,551 hydrochloride (ICI 
Pharmaceuticals, England). All drugs were dissolved 
in 0.9% saline. 
Statistical Analysis of Data 
Data in text and figures are presented as mean ± 
SEM for the indicated number of rats. Analysis of 
variance (ANOVA) with repeated measures andANO-
VAfollowed by Dunnett's or Student-Newman- Keuls 
test as weH as Student's t test w~re used for statistical 
evaluation of data. 
Results 
Cardiovascular Elfecrs of i.c. v. TRH in lntact Rats 
Blood pressure and heart rate (Figure 1 ). Admin-
istration of increasing doses of i.c. v. TRH (8 pmol-80 
nmollkg) increased MAP and pulse pressure dose-
deJ)endently; the increase in lieart rate was small and 
did not follow a dose-response relation. The maximum 
increases in all these variables were achieved 2-5 
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minutes after the injections, and the effect was com-
pletely abolished in 15-20 minutes. lntravenous in-
jections of TRH (0.8-80 nmollkg) had no significant 
effect on blood pressure or heart rate. 
Cardiac outpur and total peripheral resistance 
(Figure 1 ). Injection of TRH (8 pmol-80 nmollkg) 
dose-dependently increased the cardiac index. The 
maximum increase in cardiac index was achieved by the 
8-nmol/kg dose. The increases in cardiac performance 
became apparent concomitantly with the increments in 
blood pressure and heart rate reaching their peak effect 
5 minutes after TRH administration. The 8-nmol/kg 
dose of TRH slightly decreased TPR index (TPRI) 
(p<0.05 versus saline, Student-Newman-Keuls test). 
The other doses of TRH also tended to reduce TPRI, 
but the effect did not reach statistical significance. 
Repeated injections of saline i.c.v. (10 !J.llrat) had no 
significant effect on cardiac index or TPRI. 
In a separate set of rats, the central venous pressure 
was also monitored (Table 1). TRH (i.c.v.) has no 
significant effect on venous pressure in these rats 
despite the marked increment in cardiac index. Vali-
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FIGURE I. Maximum changes in cardiovascular variables after i.c. v. or i. v. administrations ofTRH. Saline or increasing 4oses of 
TRH were administered i.c.v. or i.v. at 20-45-minute intervals. Values represent mean±SEM. n=8-23. *p<0.05, **p<O.O/, 
statistical significance (Student-Newman-Keuls test). Compared with TRH i. v., increases in mean arterial and pulse pressure induced 
by TRH i.c. v. are significant atthe doses of 800 pmol-80 nmollkg (p<0.05-0.01), and the increase in heart rate is significant at 
the highest dose (p<0.05). BaseUne levelsfor mean arterial andpulse pressure were I 12 ±2 and50±3 mm Hg in the control group, 
115±2 and52±3 mm Hg in the i.c.v. TRH group, and /J4±1 and 50±3 mm Hg in the i.c.v. TRH group, respectively. Levelsol 
heart rate in the corresponding groups were 432 ± /, 400 ± 8, and 452 ±I beatslmin, respectively. Baseline Ievels of cardiac index 
and total peripheral resistance index in the controlgroup were 442 ± 15 mllminlkg and 0.25 ±0.01 mm Hglml!minlkg, respectively. 
Corresponding values for the TRH i.c.v. group were 462 :t 13 mllminlkg and 0.26±0.01 mm Hglml!minlkg, respectively. 
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Table I. Etrect of TRH on Arterial and Venous Pressure in tbe Consclous Rat 
Maximal change after 
Control TRH Volume Ioading Hernarrhage 
MAP (nun Hg) 118±7 +21 ±3t +9±3t -68±6t 
HR (beats/min) 414±9 +75±9* -13± 12 +66±27 
PP (mm Hg) 47±5 +22±9* +6±2 +23±7* 
CVP {mm Hg) 1.45±0.61 0.9±0.6 +2.51 ±0.83* -2.38±0.65* 
CI (mVminlkg) 350±22 +121±23* + 149± 16* -190±37* 
TPRI (nun Hglmllminlkg) 0.34±0.03 -0.09±0.02* -0.08±0.01* -0.05 ±0.01* 
A single dose ofTRH (8 nmoVkg) was injected i.c.v. For comparison, theeffects ofvolume loading (0.2 m1 saline/100 
glmin over 15 minutes) and hemorrhage (6 ml/300 g/5 min) are shown. Number of rats is 6 in TRH group and 4 in the 2 
other groups. MAP, mean a.rterial pressure; HR, heart rate; PP, pulse pressure; CVP, central vcnous pressure; Cl, cardiac 
index; TPRI, total peripheral resistance index. 
• p<O.OS, t p<O.OI statistically significant from control (Dunnen's test). 
dation of central venous pressure measurements by 
volume Ioad and hemorrhage revealed an increase in 
central venous pressure after the former Stimulus and 
a decrease of central venous pressure after the latter 
stimulus (Table I). 
Regional bloodjlow and vascular resistance ( Figure 
2 ). TRH (8 pmol-80 nmoVkg) induced dose-dependent 
EFFECT Of TRH I.C.V. ON BLOOll FlOW AMD 
VAICULAR RESISTANCE IN THE CONSCIOUS RAT 
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FIGURE 2. Maximum changes in regional blood jlow and 
vascular resistance induced by i. c. v. TRH. Saline and increasing 
doses of TRH were administered i. c. v. at 20-40-minutt intu-
vals. Values represent mean ±SEM, n =8-14. Each group 
comprised 10-15 rats. Statistical significance is given as p 
values by Student-Newman-Keuls test. TRH-inductd changes in 
hindquarter and mesenuric blood flow at dosts of 8 pmol-8 
nmoUkg andin renal blood jlow aJ doses oj 80 pmol-8 nmollkg 
wtre significant compared with saline i.c. v. (p<O.OS-0.01). 
lncrenunts in mtsenteric and renal WJScular resistance wue 
significant (p<0.05-0.0J) at all dosts, and the decrease in 
hindquarter resistance was signi.ficant at doses of 80 pmol-8 
nmoUkg (p<0.05 ). 
decreases in mesenteric and renal blood ftow accom-
panied by simultaneous increases in the renal vascular 
resistance. The blood flow to hindquarter increased, 
but there was only a slight decrease in the hindquarter 
vascular resistance. Intravenous injection of 0.8-800 
nmol/kg TRH bad no effect on blood flow or vascular 
resistance in any of the blood vessels studied (results 
not shown). 
Jnfluence of Adrenergic Blockers on Hemodynamic 
Responses to TRH 
E.ffect of phentolamine and propranolol. The effects 
of phentolamine (2 mglkg i.v.) and propranolol (2 
mgfkg i. v.) on systemic and regional hemodynamic 
variables are shown in Table 2. Baseline Ievels ofblood 
pressure, heart rate, cardiac index, and TPRI before 
phentolamine were 121 ± 5 mm Hg, 418 ± 35 beats/ 
min, 458 ± 35 mllminlkg, and 0.25 ± 0.02 mm Hglml/ 
kg/min. The corresponding values before propranolol 
treatment were 118 ± 5 mm Hg, 411 ± 8 beats/min, 
Table 2. Etrect of Pbentolamlne and Propranolol on Hemo-
dynamlc Variables in tbe Consdous Rat 
&MAP (nun Hg) 
4HR (beatslmin) 
ACI (ml!minlkg) 
ATPRI (nun Hglmllminlkg) 
ABlood ftow (%) 
HQ 
R 
M 
AResistance (%) 
HQ 
R 
M 
Phentolamine 
(n=5-13) 
-30±.5t 
+ 120±20t 
+30±29 
-0.09±0.01 
+40± 14* 
-17±11 
-21 ±7• 
-39±8t 
+ II ± 15 
+9±11 
Propranolol 
(n=6-18) 
+ 12±3* 
-51± llt 
-35±29 
+0.02±0.01 
-24±7• 
0±8 
+76±21• 
+ 10±8 
+ 18 ± 19 
Phentolamine (2 mglkg) or propranolol (2 mg/kg) was injected 
i. v. V alues (mean ±SEM) indicate changes 15 or 20 minutes after 
pbentolamine or propranolol, respectively. 
MAP, mean arterial pressure; HR, heart rate; CI, cardiac index; 
TPRI; total peripheral resistance index; HQ, hindquarter; R, renal; 
M, mesenteric. 
• p<O.Ol, t p<O.OOI vs. baseline (Student's paired 1 test). 
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Table 3. Effect of Pbentolarnlne and Propranolol on Hemodynamic Actlons of TRH l.c. v. in tbe Consclous Rat 
dMAP 6HR 6CI 6TPRI 
n (nun Hg) (beatslmin) (rn)Jminlkg) (mm Hg/mllminlkg) 
Saline I I +S± I +23±9 -8± 12 +0.02±0.01 
TRH I I . + 18±2t + 118± 14§ + 163± 19§ -O.OS±O.OU 
Phentolamioe + TRH 5 + 3 ±4t + 16 ± 7t + 113 ± 26§ -9.02 ± O.OU 
Propranoloi+TRH 6 + 16±4t +29± 12t +48±9tt 0.00±0.01* 
Phentolamine or propranolol (2 mg/kg) was injected i.v. 15-20 minutes before TRH (~ nmoVkg i.c.v.). Values 
(mean ±SEM) represent maximum changes within I S minutes after saline or TRH injection. MAP, mean arterial 
pressure; HR, hean rate; CI, cardiac index; TPRI, total peripheral resistance index. 
*p<0.05 and tp<O.OI vs. TRH i.c.v.; tp<O.OS and §p<O.Ol vs. saline (Student-Newman-Keuls test). 
464±28 ml/minlkg, and 0.24±0.02 mm Hg/ml/ 
minlkg. Phentolamine significantly lowered blood 
pressure and TPR but increased heart rate and hind-
quarter blood ftow. Propranolol increased blood pres-
sure and hindquarter vascular resistance and caused 
a slight bradycardia. 
The influence of phentolamine or propranolol on the 
hemodynamic effects of TRH is demonstrated in Table 
3 and Figure 3. Phentolamine totally abolished the 
pressor and vasoconstrictor effects of i.c.v. TRH. The 
TRH-induced tachycardia was also attenuated in 
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FrGURE 3. lnjluence of phentolamiM and propranolol on 
hemodyfUl11fic actions of TRH. Pizemolamine (2 mglkg) or 
propranolol (2 mglkg) was injected i. v. 15-20 minute.s before 
TRH (8 nmoUkg i.c.v.). Values (mean±SEM) represent maxi-
mum changes within 5 minutes after TRH admini.stration 
(mean ±SEM). Number ofrats is given in parentheses. Asterisks 
and daggers cknote statistical significance by Student-Newman-
Keuls test. 
phentolamine-treated rats. The baseline Ievel of heart 
rate was, however, markedJy increased after phentoJ-
amine treatment (586 ± 5 beaWmin versus 397 ± I 0 
beats/min, p<0.01 by Student-Newman-Keuls test). 
Propranolol partially blocked the increase in cardiac 
index, heart rate, and hindquarter blood ftow and the 
decrease in TPR. by i.c. v. TRH. The renal blood ftow 
increased after TRH in phentolamine-treated rats. 
E.ffect of practolol and /Cl 188,551. The influence 
of practolol (10 mglkg i.v.) and ICI 188,551 (1 or 2 
mg!kg i. v.) on the systemic and regional hemod ynamic 
responses to epinephrine i. v. and TRH i .c. v. are 
demonstrated in Table 4. The baseline Ievels of MAP 
and heart rate in saline-, practolol-, and ICI l88,55I-
treated groups were 119 ± 3 mm Hg and 387 ± I 0 
beats/min (n = 25), ll9±4 nun Hg and 371 ± I2 
ILU li'TmAI. 
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FrGURE 4. ln.fluence of chlorisondamine on hemodynamic 
actions of TRH. Chlorisondamine (5 mglkg) injected i. v. 20 
minutes before TRH (8 nmollkg i.c.v.). Values (mean ~SEM) 
represent ma.ximum clumges wirhin 5 minutes after TRH 
admini.stration. Number of r.ats is given in parentheses. Aster-
isks tknote statistical significance by Stwhnt-Newman-Keuls 
test. 
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Table 4A. ~fluence of Practolol (ß1-Adreooceptor Blocker) and ICI 188,551 (ß2-Adreooceptor Blocker) on 
Systemlc Hemodynamic Responses to EPI aod TRH in tbe Consclous Rat 
~p AHR 6CI ATPRI 
n (nun Hg) (beats/min) (mllminlkg) (mrn HglrnUminlkg) 
EPI i.v. 
EPI after PRACf 
EPI after ICI 
TRH i.c.v. 
12-23 
6-13 
6-12 
12-23 
6-13 
+34±4 
+39±5 
+47±9 
+18±2 
+14±4 
beats/min (n = 13), and 124 ± 5 mm Hg and 362 ± 18 
beats/min (n = i 2), respectively. The Ievels of cardiac 
index and TPRI before norepinephrine and TRH 
administration in ~ese groups ~ere 439 ± 16 
ml/minlkg and 0.26±0.01 mm Hg/ml/minlkg (con-
trol, n = 12), 482 ± 22 ml/minlkg and 0.23 ±0.02 mm 
Hg/rnl!minlkg (practolol, n = 6), and 453 ~ 19 ml! 
minlkg and 0.25±0.01 mm Hg/ml/minlkg (!Cl 
188,551, n = 6). There were no significant differences 
in the baseline Ievels of blood ftow and vascular 
resistance between these groups except for the mesen-
teric vascular resistance, ·which was significantly in-
creased in the ICI 188,551-treated rats (18±2 mm 
HglkHz in control versus 31 ± 8 mm HglkHz, 
p<0.05). Practolol (IOmglkg i. v.) blocked the·increase 
in cardiac index induced by epinephrine ( 1 ~J.g/kg i. v.) 
but had no effect on the blood pressure or regional 
hemodynarnic effects of epinephrine (Table 4). At the 
peak of the hindquarter vasodilation 2 minutes after 
TRH (8 nmollkg i.c.v.), practolol totally blocked the 
increase in cardiac index but had no effect on the 
regional hemodynamic responses to i.c. v. TRH (Table 
4). The selective ß2-adrenoceptor blocker ICI 188,551 (1 or 2 mgtkg i. v.) totally abol ished the increase in 
hindquarter blood ftow and reversed the decrease in 
hindquarter vascular resistance induced by epinephrine 
( 1 ~J.g/kg i. v.). ICI 188.551 selectively blocked the 
hindquarter vasodilation produced by TRH and sig-
nificantly potentiated its pressor response but had no 
effect on the rise in cardiac index induced by TRH. The 
TRH effects on cardiovascular variables were signifi-
-24± II 
-23± 10 
-3± 16 
+21±11 
+8±8 
+ 111 ±27 
-4± 19t 
+ 128± 15 
+67± 15 
-87±57t 
-0.01 ±0.02 
+0.07±0.02 
+0.03±0.03 
+0.03±0.04 
cant as compared with i.c. v. saline except for the heart 
rate, which was not significantly increased 2 minutes 
after TRH administration. · · 
lnjiuence of Ganglion Blocker Chlorisondamine 
The effects of chlorisondamine on TRH-induced 
hemodynamic changes are demonstrated in Figure 4. 
Chlorisondamine (5 mglkg i. v.) decreased MAP but 
had no significant effec~ on the baseline Ievels of heart 
rate or regional blood ftow before TRH administration. 
Chlorisondamine totaJly blocked the pressor and va-
soconstrictor ·effects of i.c. v. TRH and effectively 
inhibited the hindquarter vasodilation by TRH 
(Figure 4). · · 
lnjluence of Captopril and Sari ,llt!-Angiotensin J/ 
(Table 5A) 
Pretreatment with captopril ( 1. 5 mg!kg i. v.) and 
Sar1 ,IIe8-Angll (0 .1 mg/kg i. v.) had no significant effect 
on the baseline Ievels of blood pressure or regional 
blood flow before TRH injection. TRH-induced 
changes in blood pressure and regional blood ftow were 
not altered by captopril and Sar' ,Ile'-Angll. 
lnjiuence of Vasopressin Antagonist (Table 58) 
Treatment of rats with vasopressin pressor antagonist 
PMP'-0-methyl-1Yr-[Arg8]vasopressin bad no effect 
on the resting values ofblood pressure or regional blood 
ftow. The vasopressinantagonistalso failed to alter the 
pressor and regional blood flow responses to i.c. v. 
TRH. 
Table 48. lnßueuce or Practolol (10 mg/kg l.v.) aud ICI 188,551 (1 or 2 mg/kg l.v.) oo Regional HemodynamJc Cbaoges to 
EplnephriDe (1 p.g/k.g l.v.) aud TRH (8 nmol/kg l.c.v.) ID tbe Coosdous Rat 
ABiood flow (%) AVascular resistance (%) 
n HQ R M HQ R 
EPI i.v. 13 +56±8 -62± 10 -98±2 -10±6 +799± 110 
EPI after PRACf 7 +49±9 -66± 18 -96±9 -7±7 +891 ±506 
EPI after ICI 6 0± 18• -83± 10 -99±1 +51 ±23• + 1,140±900 
TRH i.c.v. 13 +53±7 -22±11 -31 ±3 -2.5±4 +60±34 
TRH after PRACf 7 +33±7 -19±5 -30±5 -19±7 +39± 12 
TRH after ICI 6 O±St -28± 13 -30±8 -19±6t +95±69 
HQ, hindquarter, R, renal; M, mesenteric; EPI, epinephrine; PRACf, practolol; ICI, ICI 188,.551. 
•p<O.OS, tp<O.OI vs. changes before PRACf or ICI 188,551 (Student-Newman-Keuls test). 
M 
+.5,070± 1,168 
+ 3,312± 1,.531 
+4,416±2,451 
+66±5 
+50± 14 
+88±27 
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Table SA. Etr~ of Captopril and Sar1 ,De1-Anglotensin ß 
(Sar~ ,De1-Angll) on Hemodyn.B.m1c Responses to TRH l.c. v. in 
the Consdous Rat · 
L\MAP AR.esis~ce (%) 
(nun Hg) HQ R M 
Saline +3±3 -3±3 +2±3 +4±3 
TRH before 
treatment + 17±2t -26±5• +37±16 +73±24t 
TRH after 
treatment .+16±4t -20±5• +20±12 +55±24• 
Captopril ( 1-.5 mglkg) and Sar1 ,lle'-Angll (0.1 mglkg) were · ad-
ministered intravenous~y 15 and 5 minutes, respectively, before 
TRH (8 nmoVkg i.c.v.). Values represent maximum changes after 
the administratioo of TRH (mean ±SEM), n = 6. 
•p<0.05, tp<O.Ol, statistical significance from saline i.c.v. 
(Student·Newman·Keuls test). · 
Effect of Centrally Administered TRH in Adrenal 
Demedullated Rats ( Figures 5 and 6) 
Baseline Ievels of hemodynamic variables before 
TRH administration in intact and Adm-·x rats are shown 
in Table 6. The cardiovascular effect of TRH (8 
nmoVkg i.c. v.) in Adm-x ratswas cömpared with that 
in intact rats. The increases in blood pressure, heart 
rate, and cardiac index induced by TRH were signif-
icantly attenuated in Adm-x rats. Additionaltreatments 
with bretylium did not significantly modify these 
effects .. 
The renal vasoconstriction induced by i.c. v. TRH 
was significantly blocked by Adm-x. Additional treat-
ment of the Adm-x rats with bretylium had no further 
effect on renal blood ftow or vascular resistance but 
significantly attenuated the increase in hindquarter 
i ] 
+ 
4 + 
MEAN ARTERIAL PRESSURE 
Adm·l Atlm-1 + tntylum 
OSAUIIE LC.V. (16) 
I7J T1fH LC.V. (11) 
•P<O.O!I 
.. P<0.01 
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'fable SB. Effect of Vasopressin ~tagonlst oo Hemodynam-
lc Responses to TRH l.c. v. lo tbe Coosdous Rat 
AMAP ~esistance (%) 
(nun Hg) HQ R M 
Saline -1±4 -1±6 +5±7 +7±14 
TRH before 
treatment +21 ±4t +9±10 +52±7• + 122±2~ 
TRH after 
treatment +16±5• +6±5 +39±15* +81±31* 
PMP1-0-methyl-Tyr2-[Arg')vasopressin (ISO 1-Lglkg) was inject-
ed i.v. 5 minutes before TRH (8 nmoVkg i.c.v.). Values represent 
maximum changes after TRH administration (mean ±SEM), n = S. 
MAP, mean arterial pressure; HQ, hindquarter; R, renal; M, 
meseoteric. 
·•p<O.OS, tp<O.Ol, statistical significance from saline i.c.v. 
(Student-Newrnan-Keuls test). · 
blood ftow as well as the mesenteric vasoconstriction 
produced by i.c.v. 'fRH. 
Effect of RelUll Denervation (Figure 7) 
Unilateral renal denervation had no effect on basal 
systemic or regional hemodynarnic variables. The basal 
blood ftow and vascular resistance were 5 ± 1 kHz and 
30.5 ± 6. 7 mm HglkHz in the denervated k.idney and 
6.3± 1.2 kHz and 34.3± 19.6· mm Hg!kHz in the 
innervated kidney, respectively. The renal vasocon-
strictor response to norepinephrine ( 1 J,Lg/kg i. v.) was 
not altered by the denervation: The maximum increase 
in resistance produced by norepinephrine in the intact 
k.idney was +2,261 ±969% (mean±SEM) and 
+ 2,908 ± l ,044% in· the denervated kidney. The 
TRH-induced decrease in renal blood ftow and increase 
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fJGURE 5. Eff~ct of i.c. v. TRH on gross cardiovascular variables in bilattrally adrenal thmedullated (Adm-.x) rats. Br~tylium (30 
mglkg) inj~cttd i. v. 2 hours before i.c. v. administraJion of saline ( 10 p.l) or TRH (8 nmoUkg). Values represtnt ma.ximum clulngts 
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FJGURE 6. Effecl of i. c. v. TRH on regional blood jlow and vascular resistance in bilaterally adrtnal thmedullated (Adm-x) rats. For 
furtMr details, see Figure 5 legend. 
in renal vascular resistance were not inftuenced by the 
denervation. 
Effects of TRH in Sinoaortic Baroreceptor-
Denervated Rats (Figure 8) 
The pressor and cardiac acceleration effects of i.c. v. 
TRH (8 nmoVkg) were significantly enhanced in SAD 
rats as compared with intact rats, although the baseline 
MAP and heart rate (140 ± 7 mm Hg and 477 ± 12 
beats/min) were significantly higher than in the control 
group (122±5 rnm Hg and 375±6 beats/min, 
p<0.05). The increase in hindquarter blood ftow and 
decrease in mesenteric blood flow were also signifi-
cantly potentiated in SAD rats. Also, the rise in 
mesenteric vascular resistance was significantly poten-
tiated in SAD rats. There was no statistically significant 
difference in the renal TRH response between the SAD 
and intact animals, although a strong trend for poten-
tiation of the renal response is evident. 
Ejfect of Systemically Administered TRH 
Effects of TRH on systemic and regional hemody-
namic variables (Table 7). Injection of a single dose of 
TRH (5.5 ~LmoVkg) into the arterial line induced 
short-lasting increases in MAP, heart rate, and cardiac 
index with no effect on TPR. The maximum changes 
were reached 5-10 minutes after the TRH injection, 
and the effects subsided within 20 minutes. This dose 
of intravenous TRH also induced a similar pattem of 
blood flow changes as seen after 8 pmoVkg i.c.v. TRH: 
a brief inccease in hindquarter blood flow (max 
+ 41 ± 7%) with a concomitant decrease in vascular 
Table 6. BaseUne Levels of Hemodynam.Jc Variables Berore Ad.m.lnlstration of TRH l.c. v. in th~ CoDScious Rat 
n Iotact Adm-x Adm-x + bretylium 
MAP (nun Hg) 16 118±3 112±2 100±3t§ 
HR (beats/min) 16 387±8 424± 16 423± 13 
CI (rnllminlkg) 8-10 442± 18 395± 13 433± 18 
TPRJ (mm Hgtml!minlkg) 8-10 0.26±0.01 0.28±0.01 0.24±0.01:1: 
Blood ftow (kHz) 
HQ 5-8 4.3±0.7 3.0±0.3 4.8±0.7 
R S-6 4.6± 1.0 5.9±1.4 6.1 ± 1.4 
M 5-7 5.6±0.8 3.0±0.4* 3.8±0.7* 
Resistance (mm HglkHz) 
HQ S-8 34±6 38±6 21±3 
R 5-6 38±8 29±7 18±4 
M 5-7 24±4 39±5 33±6 
MAP, mean arterial pressure; HR, hean rate in intact and adrenal clemedullated rats; Cl, card.iac index; TPRJ, totaJ 
peripheral resistance index; HQ, hindquarter; R, renal; M, mesenteric; Adm-x, adrenal demedullated. 
*p<O.OS, tp<O.OI, statistically different from intact rats. 
tp<0.05, §p<O.OI, statistically different from Adm-x rats. 
Mean±SEM; n, number of animals. 
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resistance (max -19±3%). Blood flow in the mes-
enteric and renal vascular beds decreased with a 
maximum drop of -24 ± 9% and - 25 ± 6%, respec-
tively. Vascular resistance in the mesenteric and renal 
arteries increased significantly ( + 41 ± 9% and 
+58± 12%, respectively). The maximum changes in 
blood flow and vascular resistance in all of these 
vascular beds became apparent 1-3 minutes after the 
systemic TRH administration and completely subsided 
after I 0-20 minutes. 
Effect ofTRH on plasma catecholamines, Vasopres-
sin, and plasma renin activity (Table 8). In intact rats, 
the intra-arterial injection of TRH (5. 5 ~tmollkg) 
caused a pronounced increase in plasma epinephrine 
and a small increase in plasma norepinephrine. The 
maximum increases in plasma catecholamines were 
observed 5 minutes after TRH injection, and the Ievels 
were back to baseline within 30 minutes after the TRH 
administration. 
A comparison of the hemodynamic changes and 
plasma Ievels of epinephrine after intravenous admin-
istration of increasing doses of epinephrine (0 .l-1 
JLg/kg) is demonstrated in Figure 9. Marked pressor and 
vasoconstrictor responses in renal and mesenteric 
vascular beds were found at plasma Ievels of epineph-
rine comparable to or even lower than those produced 
by TRH. The hindquarter vascular resistance was not 
significantly altered, while blood flow to hindquarters 
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Table 7. Eff'ec:t of Systemlcally Admlnlstered TRH (5.5 ILIDOI/kg t.a.) oo Systemic and Regional Hemodynamlc 
Variables in the Consdous Rat 
~MAP .1HR Ii CI Ii TPRI 
(mm Hg) (beatslmin) (ml/minlkg) (mrn Hg/mUminlkg) 
Saline -2±2 -2±4 +9±23 +0.01 ±0.01 
TRH + 16±2t +48± 10• +83±7• -0.01 ±0.01 
~Biood flow (%) ~esistance (%) 
HQ R M HQ R M 
Saline +1±1 +1±1 +1±1 +1±2 +1±2 +1±1 
TRH +41 ±7t +25±6t -24±9• -19±3t +58± 12t +41 ±9• 
MAP, mean arterial pressure; HR, heart rate; CI, cardiac index; TPRI, total peripheral resistance index; HQ, 
hindquarter; R, renal; M, mesenteric. 
•p<0.05, tp<O.OI, statistically different from saline i.c.v. (Student-Newman-Keuls test). 
Mean ±SEM; maximum changes after TRH administration; n = 8-15. 
was increased slightly ( + 20 ± 6%, p<0.05 versus 
saline). 
In Adm-x rats, the basal Ievels of epinephrine were 
not detectable, while norepinephrine Ievels were mark-
edly reduced (Table 6). Bretylium treatment dropped 
plasma norepinephrine concentration below detection 
Ievel. PRA was not affected by TRH in either intact or 
Adm-x rats, while plasma vasopressin concentration 
was slightly elevated (Table 8). 
Discussion 
The present study confirms and extends previous 
reports that implicate TRH as a neurotransmitter in 
Table 8. Elfect of Systemlcally AdminJstered TRH (5.5 
#LißOI/kg l.a.) 00 Plasma Levels or Catecholamlnes, Vasopres-
sin, and Plasma Renln Actlvity in the lntact and Adrenal De-
medullated (Adm-x) Consclous Rat 
Adm-x+ 
lntact rats Adm-x rats bretylium 
EPI (pg/ml) 
Baseline 240±40 <29f <29:j: 
Maximum 1,053±205t <29f <29:j: 
(n=7) (n=5) (n=S) 
NE (pglml) 
BaseliDe 259±52 73± 15 <29* 
Maximum 471±125• 79± 16 <29:j: 
(n=7) (n=5) (n=5) 
PRA (Al nglmUh) 
Baseline 16±2 24±3 24±9 
Maximum 21 ±S 44±9 41 ::t 13 
(n=6) (n=S) (n=S) 
Vasopressin (pglml) 
Baseline 2.1±0.3 NT NT 
Maximum 6.0± 1.5t 
(n=7) 
Bretylium (3 x 10 mg/kg) was injected into the arterial line 2 
bours before TRH administration. Baseline, Ievel before TRH in-
jections; maximum, Ievel at 5 minutes after TRH administration; 
EPI, epinephrine; NE, norepinephrine; PRA, pJasma renin activity; 
NT, not tested; AI, angiotensin I. 
•p<O.OS, tp<O.OI vs. baseline (Student'sttest). Mean ±SEM. 
*<29, Ievels bclow Iimit for detection, which is 29 pg/rnl, or 2.9 
pgltube. 
central cardiovascular control. Thus, TRH produced 
pressor and tachycardic.responses when injected i.c. v. 
at doses that had no effect when injected systemically; 
in fact, more than 100,000-fold of the i.c. v. dosewas 
necessary to produce comparable hemodynamic re-
sponses by systemic administration of TRH. These 
observations are in ·accord with previous studies in 
several species (see beginning of text). The present 
study further demonstrates that in the conscious rat, an 
increase in cardiac outpul is the primary mechanism of 
the pressor effect of TRH. Several mechanisms could 
have been involved in the increase in cardiac index by 
TRH. Behavioral changes after TRH administration 
(general excitation) could have mediated part of the 
increase in cardiac index. However, the pattem and 
time course of the behavioral responses to TRH were 
different from those of the vasomotor responses; 
increased locomotive activity, vigorous head shaking, 
and tremor of the paws were evident immediately after 
i.c. v. injections of TRH in some animals, while in 
others, only mild head shaking was observed 10-20 
minutes after TRH injection. On the other hand, 
hemodynamic changes consistently became apparent 
within I minute after TRH administration and subsided 
in 20 minutes. Venoconstriction and an increased 
cardiac preload (due to behavioral excitation) as 
contributing factors to elevated cardiac index seem 
unlikely since central venous pressure remained un-
changed at all times after i.c.v. TRH. Tachycardia, 
increase in cardiac contractility, and a fall in afterload 
due to decrease in TPR might all contribute to an 
increase in cardiac index. However, the tachycardia 
elicited by TRH was rather modest ( 1 0%) compared 
with the marked increase in effect on cardiac index 
( 40%). Also, the TPR decreased sl ightly only afterhigh 
doses of TRH. Thus, a positive inotropic effect on the 
heart might be the major determinant of the increase in 
cardiac index produced by TRH. 
In spite of the Iack of effect of TRH on TPR, 
substantial peripheral organ blood ftow changes were 
observed after i.c. v. TRH; while increases in renal and 
mesenteric vascular resistance led to decrements in the 
respective organ blood flow, the blood flow to the 
hindquarter increased. The increase in hindquarter 
blood flow was not merely the result of the increase in 
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systemic arterial pressure but was also clearly contrib-
uted to by hindquarter vasodilation. In this respect, our 
data are in agreement with a recent report showing 
decreases in gastrointestinal and renal blood flow 
(measured by microspheres) after systemic injections 
of TRH in the conscious rabbit. 37 The blood flow to 
skeletal muscles, however, was not affected by TRH in 
the rabbit. 37 
TRH (i.c. v.) was previously shown to attenuate the 
reftex bradycardia in response to a pressor stimulus in 
the conscious rat, 38 and therefore, the increase in blood 
pressure and heart rate induced by TRH were inter-
preted as the result of interference in the baroreflex 
regulatory mechanism. In our study, however, all of the 
reported effects of i.c. v. TRH in intact rats were 
markedly potentiated in SAD rats. These results clearly 
indicate that TRH does not produce its hemodynamic 
effects by interference in the baroregulatory circuits; in 
fact, the moderate effects of TRH in conscious intact 
animals is due to the tight baroregulatory control. The 
difference between the stud ies might be the resul t of the 
primary vagal mediated response to a peripheral pressor 
stimulus, which is counterbalanced by the concomitant 
activation of the sympathetic system by TRH in intact 
rats. In SAD rats, however, the unbalanced sympathetic 
activation is the driving force for the pressor and 
cardiac acceleration produced by TRH. Thus, reftex 
bradycardia might not be a proper procedure to evaluate 
the effect of substances on the baroreftex mechanism. 
These data also imply that in rats in which the 
baroregulatory reftexes are deranged, e.g., spontane-
aus (genetic) hypertensive rats, increased activity of 
TRH-ergic system might Iead to excessively high blood 
pressure. This hypothesis remains to be examined. 
Several recent studies addressed the role of the 
various pressor systems in mediation of the hemody-
namic responses to TRH. In contrast with a previous 
report,39 our present findings, based on direct assays of 
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(lllndti)30/ 
0....._--~-~ 
a.1 u 1.0 
LOII DOR (pglkg) 
151 
PRA and combined pharmacologic antagonists, sug-
gest no involvement of the renin-angiotensin system in 
the cardiovascular actions of TRH. The role of Vaso-
pressin was also ruled out by showing that plasma 
vasopressin does not reach the Ievels that might produce 
pressor responses. 40 Also, pharmacologic antagonism 
of Vasopressin receptors failed to inftuence the cardio-
vascular actions of TRH. In this regard, our data are in 
accord with previous reportl. 4..5'41 In cantrast with the 
Iack of evidence in support for renin-angiotensin and 
the vasopressinergic systems, severallines of evidence 
strongly support a primary role for the sympathoadre-
nomedullary system in mediation ofTRH effects. First, 
plasma catecholarnines were elevated at the peak of the 
hemodynamic responses produced by TRH. The pref-
erential increase in plasma epinephrine found in this 
study is in accord with several previous reports. 12 • 1 ~· 16 • 20 
Potent hemodynamic changes could also be produced 
by plasma epinephrine concentrations, which were 
comparable or even lower than those el icited by TRH 
(Figure 9, Yamaguchi and Kopin42). The pattern of 
blood ftow changes induced by TRH is identical tothat 
of changes produced by epinephrine. Furthermore, a 
marked activation of efferent renal sympathetic nerve 
activity by TRH was demonstrated in a recent study.~ 
In preliminary studies by our laboratory, a profound 
increase in renal sympathetic activity was also found 
aftercentrat injections ofTRH in anesthetized rats. Of 
interest, the sympathetic activation was demonstrated 
even at TRH doses that had no effect on blood pressure 
or renal blood ftow and always preceded the vasomotor 
responses. 
Second, the cardiovascular effects of i.c.v. TRH 
were abolished by ·ganglion blockade with chlorison-
damine and by pharmacologic antagonists of a- or 
ß-adrenergic receptors. The ß-blocker propranolol 
blocked most of the increase in cardiac rate and output 
and completely abolished the hindquarter vasodilation. 
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The roJe of ß2-adrenoceptors in mediation of TRH-
induced hindquarter vasodilation has been establ ished 
by blockade of the vascular ß2-adrenoceptors with ICI 
188,551; this ß2-antagonist totally abolished the in-
crease in hindquarter blood ftow and reversed the 
decrease in hindquarter vascular resistance produced 
by TRH. ICI 188,551 did not alter cardiac effects of 
TRH. The roJe of ß2-adrenoceptors in hindquarter 
vasodilation is further supported by the finding that 
practolol (a selective ß1-blocker) had no effect on the 
TRH responsein hindquarters, although it effectively 
blocked the cardiac effects of TRH at the peak of 
vasodilation. Hindquarter vessels showed a reversed 
response to TRH in the presence of ICI 188,551 or 
propranolol- namely, an increase in resistance. Thus, 
the sustained pressor response to TRH in propranolol-
treated rats seems to result primarily from intact (and 
even hypersensitive) a-adrenergic-mediated vasocon-
striction. This possibility is supported by the effective 
blockade of the increase in MAP produced by the a 1-
and a 2-adrenergic blocker phentolamine. Of interest, 
TRH induced an increase in renal blood ftow in 
phentolamine-treated rats. Thus, a-adrerioceptors pri-
marily mediate the mesenteric vasoconstriction and 
override a vasodilation in the renal arterioles. The 
mediators ofthis effect were not further investigated in 
the present study. However, dopamine released from 
the adrenal medulla might mediate this renal vasodi-
lation because dopamine is the only catecholamine to 
produce renal vasodilation. Other adrenal catechola-
mines acting on the /32-adrenoceptors might also 
produce. such an effect. The involvement of other renal 
vasodilator peptides, such as atrial natriuretic factor 
(ANF),43 seems unlikely because preliminary results 
from our laboratory indicated that TRH had no effect 
on plasma ANF in conscious rats. 
Although the Ievels of thyroid hormones after TRH 
injections were not monitored in the present study, the 
involvement of thyroid gland in the cardiovascular 
actions of TRH seems uni ikely for several reasons. 
First, the ganglion blockerchlorisondamine effectively 
blocked the hemodynamic changes induced by i.c.v. 
TRH. Second, in agreement with a recent study," our 
preliminary findings provided direct evidence for an 
increased pregangionic sympathetic nerve activity: 
concomitant increments of blood pressure, heart rate, 
and efferent sympathetic nerve activity in the urethane-
anesthetized rat. Third, the time course of the cardio-
vascular changes by TRH was different from that 
reported for its endocrinologic actions in conscious 
rats"'; the peak effects in systemic and regional he-
modynamic variables became apparent within 5 min-
utes after TRH administration and subsided in 20 
minutes, while the plasma Ievels ofT3 slowly began to 
increase 60 minutes after TRH. Finally, the cardio-
respiratory actions of i.c. v. TRH in rats were virtually 
unaltered by either hypophysectomy'-" or thy-
roidectomy. 46 
Additional support for the central roJe of the 
sympathoadrenomedullary system in mediation of the 
central hemodynamic effects of TRH is drawn from 
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sturlies conducted on Adm-x rats. Adm-x, per se, 
attenuated the increase in MAP, cardiac output, and 
renal and mesenteric vascular resistance; however, 
more complete blockade of TRH effect was observed 
after treatment of Adm-x rats with the adrenolytic 
compound bretylium. Residual sympathoadrenomed-
uJJary responses attributable to incomplete adrenal 
demedullation and sympathetic blockade by bretylium 
might explain the residual responses to TRH in these 
rats. However, plasma catecholamines were undetect-
able in the Adm-x-bretylium--treated rats, both before 
and during the peak of the residual TRH effect. 
Residual sympathetically mediated responses without 
changes in plasma catecholamines might be possible 
because plasma catecholamines are poor indexes for 
sympathetic tone. 45•46 This possibility is also supported 
by the data presented in this study showing Iack of 
change in plasma norepinephrine and undetectable 
Ievels of epinephrine in Adm-x rats that still showed 
significantconstrictionofthe mesenteric blood vessels, 
which were blocked only after addition of the sympa-
tholytic drug bretylium. This problem, however, needs 
further validation by simultaneous measurements and 
correlations of sympathetic nerve activity to a selected 
organ with vasomotor responses and monitoring of the 
arteriovenous difference of the circulating catechola-
mines. 
Hemodynamic responses similar to those produced 
by TRH in the present study have been reported earlier 
by electrical Stimulation of various hypothalamic and 
mesencephalic sites in the rat brain. Folkow and 
Rubinstein"7 found increases in blood pressure, heart 
rate, and hind I imb blood ftow with renal and gastroin-
testinal vasoconstriction after Stimulation of the hy-
pothalamic defense areas in the anesthetized rat. Also, 
the same pattern ofhemodynamic changes was recently 
reported by Yardley and Hilton. 48 In their study, the 
responses were evoked by electrical Stimulation along 
the rostro-caudal hypothalamus and a region ventral to 
the fornix as weil as the dorsal section of the central 
gray matter. Vasodilatation in hindquarters with renal 
and mesenteric vasoconstriction was also found after 
electrical Stimulation of the anteroventral region of the 
third ventricle (AV3V) in the conscious rat."9-~ 1 Since 
TRH and TRH receptors are abundant in these hypo-
thalamic nuclei, 7- 11 thyrotropin-releasing hormonergic 
pathways might mediate the hemodynamic changes 
evoked by electrical Stimulation of the hypothalamic 
defense area. However, discrete microinjections of 
TRH into the sensitive sides are needed to further test 
this hypothesis. 
Of interest, hindquarter vasodilation evoked by 
central electrical Stimulation was insensitive to atro-
pine or vagotomy but was greatly reduced by the 
ß-adrenoceptor blocker propranolol, the sympathetic 
blocker guanethidine, or adrenalectomy. 49-'u2 Thus, 
epinephrine released from the adrenal medulla as weil 
as sudden withdrawal of on-going vasoconstrictor tone 
have been suggested to underlie the hind-limb vaso-
dilation while the vasoconstrictor responses have 
been attributed to an activation of sympathetic 
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Table 9. Summary of Etrect of Mediators lnvolved in Region· 
al Vasomotor Responses to TRH l.c. v. in tbe Consdous Rat 
Vasomotor response in: 
Hindquarter 
Receptor 
Mesenteric 
Receptor 
Renal 
Sympathetic Adrenal 
nerves medulla 
NE EPI NE EPI 
+ 
+ + 
a 
+ + 
+,positive role; -, no role; NE, norepinephrine; EPI, epinepb-
rine. 
•Based on data by Berecek and Brody. s2 
nerves."7•49..so .. n Our present results suggest that TRH in 
the central nervous system produces hindquarter va-
sodilation by activation of sympathetic nerves and 
vascular ß2-receptors. Epinephrine derived from adre-
nal medulla was argued to also play a role in regional 
hemodynamic responses to AV3V Stimulation in the 
conscious rat since adrenal demedullation greatly 
attenuated not only the hind limb vasodilation but also 
the renal and mesenteric vasoconstriction induced by 
AV3V stimulation. 51 Since epinephrine infusion totally 
restored the responses to AV3V Stimulation in Adm-x 
rats, while blockade of catecholamine uptake to sym-
pathetic nerves reversed the epinephrine effect, these 
authors concluded that adrenal epinephrine might be 
acting as a sympathetic neurotransmitter. However, our 
present data suggest a differential role of the adrenal 
medulla and sympathetic nerves in mediation of 
vascular responses to TRH (Table 9); while hindquarter 
and mesenteric vascular responses seem to be primarily 
dependent on the sympathetic nerves, the renal vessels 
seem to be modulated by epinephrine from the adrenal 
medulla. Although the preganglionic renal sympa-
thetic nerve activity was markedly increased after 
TRH, 5 the renal vascular responses were not affected by 
complete denervation of the kidney but were abol ished 
by adrenal demedullation. Thus, activation of the 
sympathetic nerves by TRH seems to not play an 
important role in its vasomotor responses in the kidney. 
These findings underscore the importance of simulta-
neous recordings of sympathetic nerve activity with 
vasomotor responses in discrete organs. Furthermore, 
these data call attention to the roJe of the adrenal 
medulla through circulating epinephrine as a primary 
modulator of renal blood ftow. 
In conclusion, in conjunction with neuroanatomical 
and biochemical data previously reported, the data 
presented in this study support a potential role for 
TRH in central regulation of peripheral organ blood 
How and cardiac function through sympathetic nerves 
and circulating epinephrine. 
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